Published on 30 May 2024 on Zacks via Yahoo Finance
Zimmer Biomet Holdings, Inc. ZBH recently held its 2024 Investor Day and outlined its exciting long-term growth and value-creation plan as well as its strategic targets. The company provides a path for compelling and long term top-line growth, improved operational profitability, and increased free cash flow generation.
In the past five years, Zimmer Biomet experienced a significant metamorphosis, emerging as a more robust enterprise with promising prospects. Being a provider of orthopedics and medical technology, the company is committed to offering customer-focused solutions that optimize performance, lower safety risks and produce the best possible clinical results.
Growth Plan Details